Related Experiment Video
Updated: Oct 17, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
Published on: January 16, 2015
Polycomb group proteins in cancer: multifaceted functions and strategies for modulation
Sijie Wang1, Sandra C Ordonez-Rubiano1, Alisha Dhiman1
1Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University and Purdue University Center for Cancer Research, 201 S. University St., West Lafayette, IN 47907 USA.
Abstract:
Polycomb repressive complexes (PRCs) are a heterogenous collection of dozens, if not hundreds, of protein complexes composed of various combinations of subunits. PRCs are transcriptional repressors important for cell-type specificity during development, and as such, are commonly mis-regulated in cancer. PRCs are broadly characterized as PRC1 with histone ubiquitin ligase activity, or PRC2 with histone methyltransferase activity; however, the mechanism by which individual PRCs, particularly the highly diverse set of PRC1s, alter gene expression has not always been clear. Here we review the current understanding of how PRCs act, both individually and together, to establish and maintain gene repression, the biochemical contribution of individual PRC subunits, the mis-regulation of PRC function in different cancers, and the current strategies for modulating PRC activity. Increased mechanistic understanding of PRC function, as well as cancer-specific roles for individual PRC subunits, will uncover better targets and strategies for cancer therapies.
Insights
Polycomb repressive complexes (PRCs) regulate gene expression and development. Understanding their diverse functions and mis-regulation in cancer is key to developing new therapeutic strategies.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Biology
Background:
- Polycomb repressive complexes (PRCs) are crucial protein complexes regulating gene expression and cell identity.
- PRCs are broadly classified into PRC1 (histone ubiquitin ligase activity) and PRC2 (histone methyltransferase activity).
- Dysregulation of PRCs is frequently observed in various cancers, highlighting their role in tumorigenesis.
Purpose of the Study:
- To review the current understanding of how individual and combined PRCs establish and maintain gene repression.
- To elucidate the biochemical roles of specific PRC subunits.
- To explore the mis-regulation of PRC function in cancer and current therapeutic strategies.
Main Methods:
- Literature review of existing research on Polycomb repressive complexes.
- Analysis of biochemical mechanisms underlying PRC-mediated gene repression.
- Examination of PRC involvement in cancer development and progression.
Main Results:
- PRCs act individually and collaboratively to control gene expression patterns.
- Specific PRC subunits contribute distinct biochemical functions to repression.
- Altered PRC activity is a common feature in cancer, impacting cell fate and proliferation.
Conclusions:
- Further mechanistic insights into PRC function and cancer-specific roles are needed.
- Targeting PRC activity presents a promising avenue for novel cancer therapies.
- Understanding PRC subunit contributions can refine therapeutic strategies for cancer treatment.
Related Concept Videos
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Abnormal Proliferation
Epigenetic Regulation
X-chromosome...
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

